kabutan

Fuji Pharma Co.,Ltd.(4554) Summary

4554
TSE Prime
Fuji Pharma Co.,Ltd.
1,696
JPY
-54
(-3.09%)
Dec 5, 12:48 pm JST
10.93
USD
Dec 4, 10:48 pm EST
Result
PTS
outside of trading hours
1,697
Dec 5, 12:48 pm JST
Summary Chart Historical News Financial Result
PER
10.8
PBR
0.88
Yield
2.77%
Margin Trading Ratio
20.40
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
1,731 JPY 11.15 USD
Previous Close Dec 4
1,750 JPY 11.26 USD
High Dec 5, 9:00 am
1,737 JPY 11.19 USD
Low Dec 5, 11:30 am
1,685 JPY 10.86 USD
Volume
176,300
Trading Value
0.30B JPY 1.94M USD
VWAP
1710.34 JPY 11.03 USD
Minimum Trading Value
169,600 JPY 1,093 USD
Market Cap
0.04T JPY 0.27B USD
Number of Trades
653
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Mid
1-Year Average
308
1-Year High Feb 7, 2025
1,184
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 18,500 305,300 16.50
Nov 21, 2025 24,800 288,300 11.63
Nov 14, 2025 18,900 261,300 13.83
Nov 7, 2025 19,300 265,000 13.73
Oct 31, 2025 21,600 248,300 11.50
Company Profile
Fuji Pharma Co., Ltd. is a leading generic pharmaceutical company, specializing in fertility treatments and contrast agents. The company is also expanding into new drugs and biosimilars.
Sector
Pharmaceuticals
Fuji Pharma Co., Ltd. is a major generic drug manufacturer, primarily focusing on injectable products such as hormone preparations for obstetrics and gynecology, and urinary tract and vascular contrast agents for radiology. The company operates through five branch offices nationwide, engaging in the development, manufacturing, and sales of pharmaceuticals. With one consolidated subsidiary, Fuji Pharma conducts product trading and financial lending with its Thai subsidiary. Operating under a single pharmaceutical business segment, the company offers a diverse product lineup to meet a wide range of medical needs. As a pharmaceutical manufacturer with particular strengths in obstetrics, gynecology, and radiology, Fuji Pharma Co., Ltd. conducts business both domestically and internationally.